跳至主要内容
临床试验/NCT03431922
NCT03431922Unknown不适用

Endovascular Denervation in Patients With Cancer Pain

Zhongda Hospital1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2017年9月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
20
试验地点
1
主要终点
Pain relief

研究概览

简要总结

Endovascular arterial denervation (ED) is a minimally invasive technique which could reduce the occurrence of injury of visceral tissue or organs. As the principle of renal denervation (RDN), Radiofrequency energy delivered by a multi-electrode catheter to the celiac plexus over the anterolateral surface of the superior mesenteric artery (SMA) and the celiac axis. Damaged or partially damaged celiac plexus can achieve the effect of pain relief.

详细描述

The multi-electrode catheter was consisted of six independent electrodes helically on a net structure, which could be set as the same energy and temperature for simultaneous multi-point ablation. A real-time monitoring capability also provided by the display.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
25 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 25 to 75 years
  • severe cancer pain with the visual analogue scores of no less than 7

排除标准

  • pregnant or intent to become pregnant within 1 year
  • postural hypotension
  • uncorrected coagulation dysfunction
  • aortic aneurysm or dissection
  • type 1 diabetes mellitus (T1DM)
  • acute or severe systemic infection
  • history of cerebral apoplexy or transient ischemic attack (TIA) in the past two weeks
  • history of acute coronary syndrome in the past two weeks
  • participants who are not suitable to be enrolled into the study assessed by the researchers

研究组 & 干预措施

endovascular denervation

Experimental

endovascular denervation

干预措施: endovascular denervation (Device)

结局指标

主要结局

Pain relief

时间窗: from baseline to 1 months after procedure

Changes of the visual analogue scores (VAS) scores

次要结局

  • Pain relief(from baseline to 3 months after procedure)
  • Improvement of Quality of Life(from baseline to 3 months after procedure)
  • Incidence of Treatment Adverse Events(from baseline to 1 months after procedure)

研究者

发起方
Zhongda Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Gao-jun Teng

Dean

Zhongda Hospital

研究点 (1)

Loading locations...

相似试验